CARESCAPE B650, E-musb

K213181 · GE Healthcare Finland Oy · MHX · Apr 13, 2022 · Cardiovascular

Device Facts

• Record ID: K213181
• Device Name: CARESCAPE B650, E-musb
• Applicant: GE Healthcare Finland Oy
• Product Code: MHX · Cardiovascular
• Decision Date: Apr 13, 2022
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 870.1025
• Device Class: Class 2
• Attributes: Pediatric

Intended Use

The CARESCAPE B650 is a multi-parameter patient monitor intended for use in multiple areas and intrahospital transport within a professional healthcare facility. The CARESCAPE B650 is intended for use on adult, pediatric, and neonatal patients and on one patient at a time. The CARESCAPE B650 is indicated for monitoring of: · hemodynamic (including ECG, ST segment, arrhythmia detection, ECG diagnostic and measurement, invasive pressure, non-invasive blood pressure, pulse oximetry, regional oxygen saturation, total hemoglobin concentration, cardiac output (thermodilution and pulse contour), temperature, mixed venous oxygen saturation, and central venous oxygen saturation), · respiratory (impedance respiration, airway gases (CO2, O2, N2O, and anesthetic agents), spirometry, gas exchange), and · neurophysiological status (including electroencephalography, Entropy, Bispectral Index (BIS), and neuromuscular transmission). The CARESCAPE B650 can be a stand-alone monitor or interfaced to other devices. It can also be connected to other monitors for remote viewing and to data management software devices via a network. The CARESCAPE B650 is able to detect and generate alarms for ECG arrhythmias: atrial fibrillation, accelerated ventricular rhythm, asystole, bigeminy, bradycardia, ventricular couplet, missing beat, multifocal premature ventricular contractions (PVCs), pause, R on T, supra ventricular tachycardia, trigeminy, ventricular bradycardia, ventricular fibrillation/ventricular tachycardia, ventricular tachycardia, and VT>2. The CARESCAPE B650 also shows alarms from other ECG sources. The CARESCAPE B650 also provides other alarms, trends, snapshots and calculations, and can be connected to displays, printers and recording devices. The CARESCAPE B650 is intended for use under the direct supervision of a licensed healthcare practitioner, or by personnel trained in proper use of the equipment in a professional healthcare facility.

Device Story

CARESCAPE B650 is a portable multi-parameter patient monitor featuring a 15-inch touch display, CPU, and battery. It acquires physiological data via E-modules or ePort-connected acquisition devices (PDM/CARESCAPE ONE). The device integrates an E-musb interface module to communicate with OEM-owned devices (INVOS rSO2, Microstream CO2). It processes hemodynamic, respiratory, and neurophysiological signals to provide real-time monitoring, arrhythmia detection (EK-Pro V14 algorithm), and alarm generation. Used in professional healthcare settings by trained clinicians, it supports stand-alone operation or network integration for remote viewing and data management. Output includes waveforms, numeric trends, and alarms, assisting clinicians in patient status assessment and decision-making. Benefits include continuous, multi-parameter patient surveillance.

Clinical Evidence

No clinical data required. Substantial equivalence supported by bench testing, including electromagnetic compatibility, electrical safety, environmental, WLAN, usability, and software verification/validation.

Technological Characteristics

Multi-parameter monitor with 15" TFT color LCD. Connectivity via CARESCAPE Network (LAN/VLAN/WLAN). Software-based arrhythmia detection (EK-Pro V14). Hardware includes E-module slots and ePort interface. Powered by rechargeable Lithium-Ion batteries. Updated with E-musb interface for external OEM parameter modules.

Indications for Use

Indicated for monitoring adult, pediatric, and neonatal patients in professional healthcare facilities and during intrahospital transport. Contraindicated for use in controlled MR environments.

Regulatory Classification

Identification

The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.

Special Controls

*Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.

Predicate Devices

• CARESCAPE B650 (K191149)

Reference Devices

• INVOS PM7100 Patient Monitor (K182868)
• MASIMO RADICAL Y PULSE CO-OXIMETER (K110028)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is in blue and includes the letters "FDA" followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in a stacked format.

April 13, 2022

GE Healthcare Finland Oy Joel Kent Senior Regulatory Affairs Manager Kuortaneenkatu 2 Helsinki, FI-00510 Finland

Re: K213181

Trade/Device Name: CARESCAPE B650, E-musb Regulation Number: 21 CFR 870.1025 Regulation Name: Arrhythmia Detector And Alarm (Including ST-Segment Measurement And Alarm) Regulatory Class: Class II Product Code: MHX, BZK, BZL, BZQ, CAP, CBQ, CBR, CBS, CCK, CCL, DPS, DPZ, DOA, DOK, DRT, DSI, DSJ, DSK, DXG, DXN, FLL, GWJ, GWQ, KOI, KRB, MLD, MUD, NHO, NHP, NHQ, OLT, OLW, OMC, ORT, QEM Dated: March 11, 2022 Received: March 14, 2022

Dear Joel Kent:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely.

for

Jennifer Shih Kozen Assistant Director Division of Cardiac Electrophysiology, Diagnostics and Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Indications for Use

510(k) Number (if known)

Device Name CARESCAPE B650

#### Indications for Use (Describe)

The CARESCAPE B650 is a multi-parameter patient monitor intended for use in multiple areas and intrahospital transport within a professional healthcare facility.

The CARESCAPE B650 is intended for use on adult, pediatric, and neonatal patients and on one patient at a time. The CARESCAPE B650 is indicated for monitoring of:

· hemodynamic (including ECG, ST segment, arrhythmia detection, ECG diagnostic and measurement, invasive pressure, non-invasive blood pressure, pulse oximetry, regional oxygen saturation, total hemoglobin concentration, cardiac output (thermodilution and pulse contour), temperature, mixed venous oxygen saturation, and central venous oxygen saturation),

· respiratory (impedance respiration, airway gases (CO2, O2, N2O, and anesthetic agents), spirometry, gas exchange), and

· neurophysiological status (including electroencephalography, Entropy, Bispectral Index (BIS), and neuromuscular transmission).

The CARESCAPE B650 can be a stand-alone monitor or interfaced to other devices. It can also be connected to other monitors for remote viewing and to data management software devices via a network.

The CARESCAPE B650 is able to detect and generate alarms for ECG arrhythmias: atrial fibrillation, accelerated ventricular rhythm, asystole, bigeminy, bradycardia, ventricular couplet, missing beat, multifocal premature ventricular contractions (PVCs), pause, R on T, supra ventricular tachycardia, trigeminy, ventricular bradycardia, ventricular fibrillation/ventricular tachycardia, ventricular tachycardia, and VT>2. The CARESCAPE B650 also shows alarms from other ECG sources.

The CARESCAPE B650 also provides other alarms, trends, snapshots and calculations, and can be connected to displays, printers and recording devices.

The CARESCAPE B650 is intended for use under the direct supervision of a licensed healthcare practitioner, or by personnel trained in proper use of the equipment in a professional healthcare facility.

Contraindications for using CARESCAPE B650:

The CARESCAPE B650 is not intended for use in a controlled MR environment.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

{3}------------------------------------------------

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}------------------------------------------------

GE Healthcare Finland Oy Kuortaneenkatu 2
00510 Helsinki Finland T: [phone]

### 510(k) Summary

In accordance with 21 CFR 807.92 the following summary of information is provided:

Owner/Contact/Date (807.92(a)(1)):

| Date: | September 27, 2021 |
|------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Owner/Submitter: | GE Healthcare Finland Oy.<br>Kuortaneenkatu 2<br>00510 Helsinki<br>FINLAND<br>Phone: [phone] |
| Primary Contact Person: | Joel Kent<br>Senior Regulatory Affairs Manager<br>GE Healthcare<br>Phone: [phone]<br>E-mail: [e-mail] |
| Secondary Contact Person: | Karin Mårtenson<br>Regulatory Affairs Leader<br>GE Healthcare Finland Oy<br>Kuortaneenkatu 2<br>00510 Helsinki<br>Finland<br>Phone: + 358 50 384 6646<br>E-mail: [e-mail] |
| Device names (807.92(a)(2)): | |

Trade Name: CARESCAPE B650 Common/Usual Name: Multiparameter patient monitor (monitor, physiological, patient (with arrhythmia detection or alarms)

{5}------------------------------------------------

Classification Names: 21 CFR 870.1025 Arrhythmia detector and alarm (including STsegment measurement and alarm) 21 CFR 868.1850 spirometer, monitoring (w/wo alarm) 21 CFR 868.1730 computer, oxygen-uptake 21 CFR 868.2375 monitor, breathing frequency 21 CFR 868.2600 monitor, airway pressure (includes gauge and/or alarm) 21 CFR 868.1500 analyzer, gas, enflurane, gaseous-phase (anesthetic conc.) 21 CFR 868.1500 analyzer, gas, desflurane, gaseous-phase (anesthetic conc.) 21 CFR 868.1500 analyzer, gas, sevoflurane, gaseous-phase (anesthetic conc.) 21 CFR 868.1500 analyzer, gas, isoflurane, gaseous-phase (anesthetic conc.) 21 CFR 868.1700 analyzer, gas, nitrous-oxide, gaseous phase (anesthetic conc.) 21 CFR 868.1620 analyzer, gas, halothane, gaseous-phase (anesthetic conc.) 21 CFR 868.1400 analyzer, gas, carbon-dioxide, gaseous-phase 21 CFR 868.1720 analyzer, gas, oxygen, gaseous-phase 21 CFR 870.2340 electrocardiograph 21 CFR 870.2710 oximeter, ear 21 CFR 870.2700 oximeter 21 CFR 870.1425 computer, diagnostic, programmable 21 CFR 870.2300 monitor, cardiac (incl. cardiotachometer & rate alarm) 21 CFR 870.1025 detector and alarm, arrhythmia 21 CFR 870.1100 alarm, blood-pressure 21 CFR 870.1110 computer, blood-pressure 21 CFR 870.1435 computer, diagnostic, pre-programmed, single-function 21 CFR 870.1130 system, measurement, blood-pressure, noninvasive 21 CFR 870.2910 thermometer, electronic, clinical 21 CFR 882.1900 stimulator, auditory, evoked response 21 CFR 882.1400 full-montage standard electroencephalograph 21 CFR 870.2700 Oximeter, Tissue Saturation 21 CFR 868.2775 stimulator, nerve, peripheral, electric 21 CFR 870.1915 probe, thermodilution 21 CFR 870.1025 monitor, st segment with alarm 21 CFR 882.1400 non-normalizing quantitative electroencephalograph software 21 CFR 882.1400 index-generating electroencephalograph software 21 CFR 882.1400 reduced- montage standard electroencephalograph 21 CFR 882.1400 burst suppression detection software for electroencephalograph 21 CFR 870.2700 Cerebral Oximeter

{6}------------------------------------------------

Product Code: MHX

| Subsequent Product Codes: | BZK, BZL, BZQ, CAP, CBQ, CBR, CBS, CCK, CCL, DPS, DPZ, DQA, DQK, DRT, DSI, DSJ, DSK, DXG, DXN, FLL, GWJ, GWQ, KOI, KRB, MLD, MUD, NHO, NHP, NHQ, OLT, OLW, OMC, ORT, QEM |
|----------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Predicate Device(s)<br>(807.92(a)(3)): | The primary predicate for this submission is K191149<br>CARESCAPE B650 |
| | Additional predicates / reference devices:<br>K182868, INVOS PM7100 Patient Monitor, INVOS Adult rSO2<br>Sensor<br>K110028, MASIMO RADICAL Y PULSE CO-OXIMETER |
| Device Description<br>(807.92(a)(4)): | CARESCAPE B650 is a new version of a portable multi-<br>parameter patient monitoring system. The CARESCAPE B650<br>includes the monitor with built-in CPU, power unit, a 15 inch<br>touch display, the CARESCAPE Software and the battery.<br>CARESCAPE B650 is equipped with two module slots where<br>patient data acquisition modules (E-Module type) can be<br>connected to perform patient monitoring. CARESCAPE B650 is<br>equipped with the ePort interface that supports use of PDM or<br>CARESCAPE ONE patient data acquisition devices. In addition<br>to the ePort interface the PDM module can be also connected<br>directly to the CARESCAPE B650 via special slide mount<br>connector which is in the back of the monitor. The<br>CARESCAPE B650 includes features and subsystems that are<br>optional or configurable. |
| Intended Use: (807.92(a)(5)): | Indications (from labeling)<br>The CARESCAPE B650 is a multi-parameter patient monitor<br>intended for use in multiple areas and intrahospital transport<br>within a professional healthcare facility. |
| | The CARESCAPE B650 is intended for use on adult, pediatric,<br>and neonatal patients and on one patient at a time. |

The CARESCAPE B650 is indicated for monitoring of:

• hemodynamic (including ECG, ST segment, arrhythmia detection, ECG diagnostic analysis and measurement, invasive pressure, non-invasive blood pressure, pulse oximetry, regional oxygen saturation, total hemoglobin concentration, cardiac output (thermodilution and pulse contour), temperature, mixed

{7}------------------------------------------------

venous oxygen saturation, and central venous oxygen saturation),

· respiratory (impedance respiration, airway gases (CO2, O2, N2O, and anesthetic agents), spirometry, gas exchange), and

· neurophysiological status (including electroencephalography, Entropy, Bispectral Index (BIS), and neuromuscular transmission).

The CARESCAPE B650 can be a stand-alone monitor or interfaced to other devices. It can also be connected to other monitors for remote viewing and to data management software devices via a network.

The CARESCAPE B650 is able to detect and generate alarms for ECG arrhythmias: atrial fibrillation, accelerated ventricular rhythm, asystole, bigeminy, bradycardia, ventricular couplet, irregular, missing beat, multifocal premature ventricular contractions (PVCs), pause, R on T, supra ventricular tachycardia, tachycardia, trigeminy, ventricular bradycardia, ventricular fibrillation/ventricular tachycardia, ventricular tachycardia, and VT>2. The CARESCAPE B650 also shows alarms from other ECG sources.

The CARESCAPE B650 also provides other alarms, trends, snapshots and events, and calculations, and can be connected to displays, printers and recording devices.

The CARESCAPE B650 is intended for use under the direct supervision of a licensed healthcare practitioner, or by personnel trained in proper use of the equipment in a professional healthcare facility.

#### Contraindications for using the monitor

The CARESCAPE B650 is not intended for use in a controlled MR environment.

Technology (807.92(a)(6)): CARESCAPE B650 incorporates updated software and minor modifications to the hardware.

> The fundamental function and operation of the proposed CARESCAPE B650 monitor are unchanged compared to CARESCAPE B650 (K191149).

A summary of the main changes compared to the predicate are listed below in the comparison table.

{8}------------------------------------------------

| Specification | CARESCAPE B650<br>(K191149) | Proposed<br>CARESCAPE B650 | Differences |
|------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Patient type | Adult, pediatric &<br>neonatal | Adult, pediatric &<br>neonatal | Identical |
| Use<br>environments | Within a professional<br>healthcare facility (Not<br>intended for MRI) | Within a professional<br>healthcare facility (Not<br>intended for MRI) | Identical |
| Intrahospital<br>transport | Intrahospital transport<br>within a professional<br>healthcare facility. | Intrahospital transport<br>within a professional<br>healthcare facility. | Identical |
| Size (H x W x<br>D) & Weight | 360 x 370 x 220 mm (14.2<br>x 14.6 x 8.7 in) and<br>weight 9.2 kg (20.3 lbs) with<br>battery but without modules. | 360 x 370 x 220 mm<br>(14.2 x 14.6 x 8.7 in) and<br>weight 9.2 kg (20.3lbs)<br>with battery but without<br>modules. | Identical |
| Module Housing | Two E-module slots for<br>two single-width E-<br>modules or one double-<br>width E-module and<br>optional recorder. One<br>slide mount for<br>acquisition module. | Two E-module slots for<br>two single-width E-<br>modules and optional<br>recorder. One slide mount<br>for acquisition module. | Equivalent<br>Added mechanical block to E-<br>module housing mechanics and<br>removed related electronic<br>components, to prevent use of<br>double-width legacy modules, that<br>are no longer supported. There is no<br>change to functionality of the E-<br>module frame itself, only preventing<br>users from connecting legacy E-<br>modules that CARESCAPE B650<br>does not support |
| Display/screen | 15" TFT color LCD | 15" TFT color LCD | Identical |
| Waveforms and<br>parameter<br>windows | Standard view: Up to 8<br>individual waveforms and<br>up to 20 parameter<br>windows, if horizontal<br>parameter area turned on. | Standard view: Up to 8<br>individual waveforms and<br>up to 20 parameter<br>windows, if horizontal<br>parameter area turned on. | Identical |
| Modules | E-BIS, E-COP, E-<br>COPSv, E-PiCCO, E-<br>EEGX, E-Entropy, E-<br>Masimo, E-miniC, E-<br>NMT, E-NSATX, E-PP,<br>E-PT, E-sCAIO, E-<br>sCAIOV, E-sCAIOVX,<br>E-sCO, E-sCOV, E-<br>sCOVX, PDM,<br>CARESCAPE ONE | E-BIS, E-COP, E-<br>COPSv, E-PiCCO, E-<br>EEGX, E-Entropy, E-<br>Masimo, E-miniC, E-<br>NMT, E-NSATX, E-PP,<br>E-PT, E-sCAIO, E-<br>sCAIOV, E-sCAIOVX,<br>E-sCO, E-sCOV, E-<br>sCOVX, PDM,<br>CARESCAPE ONE | Identical |
| Optional system<br>components | -Remote Control<br>-CARESCAPE D19KT<br>VER01 optional display<br>-CARESCAPE RAD,<br>Remote Alarm Device<br>-Keyboard<br>-Mouse<br>-Barcode scanner<br>-Laser Printer | -Remote Control<br>-CARESCAPE D19KT<br>VER01 optional display<br>-CARESCAPE RAD,<br>Remote Alarm Device<br>-Keyboard<br>-Mouse<br>-Barcode scanner<br>-Laser Printer<br>-E-musb Interface module | Equivalent<br>Added E-musb Interface module<br>that provides a communication path<br>for the OEM owned devices<br>CARESCAPE rSO2 – INVOS and<br>CARESCAPE CO2 – Microstream<br>to the CARESCAPE Bx50 host<br>monitors |
| Available<br>measurement<br>parameters | ECG, ST segment,<br>arrhythmia detection,<br>ECG diagnostic analysis<br>and measurement,<br>invasive pressure, non-<br>invasive blood pressure,<br>pulse oximetry, cardiac<br>output (thermodilution<br>and pulse contour),<br>temperature, mixed<br>venous oxygen saturation,<br>and central venous<br>oxygen saturation,<br>impedance respiration,<br>airway gases (CO2, O2,<br>N2O, and anesthetic<br>agents), spirometry, gas<br>exchange,<br>electroencephalography,<br>Entropy, Bispectral Index<br>(BIS), neuromuscular<br>transmission. | ECG, ST segment,<br>arrhythmia detection,<br>ECG diagnostic analysis<br>and measurement,<br>invasive pressure, non-<br>invasive blood pressure,<br>pulse oximetry, regional<br>oxygen saturation, total<br>hemoglobin<br>concentration, cardiac<br>output (thermodilution<br>and pulse contour),<br>temperature, mixed<br>venous oxygen saturation,<br>and central venous<br>oxygen saturation,<br>impedance respiration,<br>airway gases (CO2, O2,<br>N2O, and anesthetic<br>agents), spirometry, gas<br>exchange,<br>electroencephalography,<br>Entropy, Bispectral Index<br>(BIS), neuromuscular<br>transmission. | Equivalent<br>Added hemodynamic parameters (in<br>bold) that are previously cleared but<br>are new to the monitor:<br>regional oxygen saturation and total<br>hemoglobin concentration, often<br>referred to as rSO2 and SpHb. The<br>Indications for Use were updated<br>accordingly.<br>The CARESCAPE B650 does not<br>change the measurement or<br>algorithm of these parameters but<br>simply displays the values from the<br>OEM owned<br>CARESCAPE parameter devices<br>CARESCAPE SpO2 –Masimo and<br>CARESCAPE rSO2 –INVOS. |
| EK-Pro<br>arrhythmia<br>detection<br>algorithm | EK-Pro V14 | EK-Pro V14 | Identical |
| Printing | Built-in or central and<br>networked laser printer<br>Printings for waveforms,<br>alarms waveforms,<br>numeric trends. | Built-in or central and<br>networked laser printer<br>Printings for waveforms,<br>alarms waveforms,<br>numeric trends. | Identical |
| Mounting<br>options | Multiple GCX mounting<br>systems, Roll Stand,<br>Quick Mount | Multiple GCX mounting<br>systems, Roll Stand | Equivalent<br>Quick Mount is obsolete and not<br>sold anymore. |
| Alarms | Alarm management core<br>functionalities:<br>Classification and notification of<br>alarms<br>Adjustment of alarm settings<br>Possibility to set critical alarm<br>limits<br>Alarm On/Off functionality and<br>audio silencing | Alarm management core<br>functionalities:<br>Classification and notification of<br>alarms<br>Adjustment of alarm settings<br>Possibility to set critical alarm<br>limits<br>Alarm On/Off functionality and<br>audio silencing | Identical |
| Battery operation | Rechargeable Lithium-Ion<br>batteries | Rechargeable Lithium- Ion<br>batteries | Identical |
| Networking<br>capability | CARESCAPE Network<br>LAN/VLAN<br>Optional WLAN | CARESCAPE Network<br>LAN/VLAN<br>Optional WLAN | Identical |
| Network<br>interface | 10baseT, 100baseT,<br>802.11 abgn, IEEE<br>802.11r fast roaming is<br>supported. | 10baseT, 100baseT,<br>802.11 abgn, IEEE<br>802.11r fast roaming is<br>supported. | Identical |

# Subject Device and Predicate Device Comparison

{9}------------------------------------------------

{10}------------------------------------------------

| Determination of<br>Substantial Equivalence<br>(807.92(b)(1): | | Summary of Non-Clinical Tests: |
|---------------------------------------------------------------|--|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | | Bench testing related to software, hardware and performance<br>including applicable consensus standards was conducted on the<br>CARESCAPE B650, demonstrating the design meets the<br>specifications. |
| | | The hardware bench testing included electromagnetic<br>compatibility, electrical safety, environmental, WLAN, and<br>usability. |
| | | Software testing included software design, development,<br>verification, validation and traceability. |
| Clinical (807.92(b)(2)): | | Summary of Clinical Tests: |
| | | The subject of this premarket submission, CARESCAPE B650<br>did not require clinical studies to support substantial equivalence. |
| Conclusion (807.92(b)(3)): | | GE Healthcare considers the CARESCAPE B650 to be as safe, as<br>effective, and the performance to be substantially equivalent to<br>the predicate device. |